Prescriptions of traditional Chinese medicine, western medicine, and integrated Chinese–Western medicine for allergic rhinitis under the National Health Insurance in Taiwan

Huang, Shou-Chieh; Ho, Yu‐Ling; Chang, Yuan‐Shiun

doi:10.1016/j.jep.2015.06.051

Cited by 21 publications

(13 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There is a growing interest in the medicinal use of traditional Chinese medicines (TCMs) [10–13]. Danggui-Sayuk-Ga-Osuyu-Saenggang-Tang (DSGOST; Danggui-Sini-Jia-Wuzhuyu-Shengjian-Tang in Chinese, Tokishigyakukagoshuyushokyoto in Japanese) has long been used in treatment of vascular diseases including Raynaud's syndrome [14–18].…”

Section: Introductionmentioning

confidence: 99%

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis

et al. 2016

View full text Add to dashboard Cite

Tumor growth requires a process called angiogenesis, a new blood vessel formation from pre-existing vessels, as newly formed vessels provide tumor cells with oxygen and nutrition. Danggui-Sayuk-Ga-Osuyu-Saenggang-Tang (DSGOST), one of traditional Chinese medicines, has been widely used in treatment of vessel diseases including Raynaud's syndrome in Northeast Asian countries including China, Japan and Korea. Therefore, we hypothesized that DSGOST might inhibit tumor growth by targeting newly formed vessels on the basis of its historical prescription. Here, we demonstrate that DSGOST inhibits tumor growth by inhibiting VEGF-induced angiogenesis. DSGOST inhibited VEGF-induced angiogenic abilities of endothelial cells in vitro and in vivo, which resulted from its inhibition of VEGF/VEGFR2 interaction. Furthermore, DSGOST attenuated pancreatic tumor growth in vivo by reducing angiogenic vessel numbers, while not affecting pancreatic tumor cell viability. Thus, our data conclude that DSGOST inhibits VEGF-induced tumor angiogenesis, suggesting a new indication for DSGOST in treatment of cancer.

show abstract

Section: Introductionmentioning

confidence: 99%

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis

et al. 2016

View full text Add to dashboard Cite

show abstract

“…Upper respiratory infection In 2009, 9.92% of upper respiratory infection(including influenza) patients used TEAM 72) Rhinosinusitis In 2000∼2011, 29% of newly diagnosed choronic rhinosinustis patients used TEAM 73) Allergic rhinitis In 2002, 2.4% of patients used western medicine, 1.4% of patients used TEAM to treat allergic rhinitis 74) In 2009∼2010, 80.5% used only western medicine, 12.73% used only TEAM, 6.77% used western medicine and TEAM in combination to treat allergic rhinitis 75) In 2009, 80.2% used only western medicine, 12.93% used only TEAM, 6.82% used western medicine and TEAM in combination to treat allergic rhinitis 76) In 2002∼2010, 63.11% of newly diagnosed child allergic rhinitis patients used TEAM 77) Asthma In 1997∼2008, 85.7% of newly diagnosed adult asthma patients used TEAM 78) In 1997∼2009, Herbal medicine was prescribed at 35.28% of total visits in school age (6∼18 years old) 79) In 2002∼2010, 57.95% of child asthma patients used TEAM 80) In 2000∼2011, Despite the gradual increase in asthma patients, the use of TEAM decreased from 38.58% to 29.26% 81) In 2005∼2010, 18.7∼23.2% of child asthma patients used TEAM 82) Diseases of the digestive system (8.30%) . 뿐만 아니라 국민건강보험제도 등 의료제도적 94) In 1997∼2011, 14.28% of the patients visited the TEAM clinic for SLE treatment 95) Diseases of the genitourinary system (16.49%) Menopausal syndrome In 1997∼2004, 64.9% of 45∼55 year old women had experience using TEAM 96) In 2002, 75.1% of patients diagnosed with menopausal syndrome had experience using TEAM 97) Infertility In 2000∼2011, 96.17% of patients diagnosed with infertility had experience using TEAM 98) Renal 104) *In parentheses, frequency of use of TEAM for Western medicine use by ICD-9 disease classification.…”

Section: 대만의 보편적 Team 이용 관련 연구mentioning

confidence: 99%

Analysis of the Medical Market Share of Traditional East Asian Medicine (TEAM) in Taiwan Using National Health Insurance Research Database (NHIRD)

Jeung¹,

Choi²,

Jo³

et al. 2018

J Korean Med Rehabil

View full text Add to dashboard Cite

Objectives Since the health insurance coverage for traditional Korean medicine is very low, some physicians and researcher have suggested that government's institutional support is needed for korean medicine field. Therefore We examine the use of traditional medicine and western medicine in Taiwan, which operates a similar health insurance system to Korea. Methods We selected several studies from Pubmed and NHIRD, that could be used to numerically evaluate the use of traditional medicine. We reviewed the current status of medical use in Taiwan and compare it with that of Korea. Results Through a total of 87 studies, We found that 26.59%∼31% of Taiwanese use Traditional medical institutions more than once a year, and the use of traditional medicine has been increasing since 2000. In adults than children, in women than men, the use rate of traditional medicine was high. Especially, herbal medicine was the most common intervention, accounting for 70% of traditional medical care. Conclusions The core of low insurance coverage for traditional Korean medicine is in lack of coverage for herbal medicine. Taiwan's case shows that the unmet demand for traditional Korean medicine of the Korean population can exist widely. (J Korean Med Rehabil 2018;28(1):133-144)

show abstract

“…Xin-Yi-Qing-FeiTang (magnolia flower lung-clearing decoction) is one of the plant-based compounds that are used to treat allergic rhinitis in China and Taiwan 8 . A study was conducted to compare Traditional Chinese Medicine (TCM) and other oriental medicine with reference to insurance files of patients with allergic rhinitis, and found that certain plants such as Xin-Yi-Qing-Fei-Tang, Shau Ching Long Tang, Shin Yee San, Tsang Err San, Jel Girng, Yu Shing Tsao, Bai Zu, and Opium derivatives have various effects to treat allergic rhinitis compared to therapies in western medicine 37 After examining nasal mucosa tissues, they reported that these plants could modulate lipid mediators (PGD2, histamine, and IL-5). In addition, the synergistic effect of the two plants was greater than their effects when they were independently administered.…”

Section: Phytotherapies Of Allergic Rhinitismentioning

confidence: 99%

Untitled

2017

IJPSR

View full text Add to dashboard Cite

Allergic rhinitis is a common disease of immune system that negatively affects general health, quality of life, and social relationships. In the recent years, many studies have been conducted to discover novel treatments for this disease particularly using natural products. Here, we review findings of recent studies that harness medicinal plants and phytotherapies in oriental medicine that have effectively reduced allergic rhinitis complications. We also assess the use of medicinal plants and their derivatives in oriental medicine to treat allergic rhinitis. In addition, these agents have been reported to be used in combination with each other or separately as complementary therapies and even, in some cases, alternative therapies instead of chemical drugs. These plants display their anti-allergy effects through affecting immunoglobulin and inhibiting different cytokines and interleukins. Medicinal plants and traditional approaches can still offer new therapeutic alternatives to researchers and pharmacists so that these alternatives may further contribute to allergic rhinitis drug discovery.

show abstract

Prescriptions of traditional Chinese medicine, western medicine, and integrated Chinese–Western medicine for allergic rhinitis under the National Health Insurance in Taiwan

Cited by 21 publications

References 11 publications

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis

DSGOST inhibits tumor growth by blocking VEGF/VEGFR2-activated angiogenesis

Analysis of the Medical Market Share of Traditional East Asian Medicine (TEAM) in Taiwan Using National Health Insurance Research Database (NHIRD)

Untitled

Contact Info

Product

Resources

About